Global healthcare company Viatris has been named to Forbes’ World’s Top Companies for Women 2024 list, an honor awarded in collaboration with Statista, a leading statistics and industry ranking provider. “At Viatris, diverse perspectives fuel innovation and our mission to…
Astellas Pharma Inc. (TSE: 4503; President and CEO: Naoki Okamura) announced today its decision to withdraw the marketing authorization application for avacincaptad pegol intravitreal solution (ACP) from the European Medicines Agency (EMA). ACP is an investigational synthetic aptamer that inhibits…
Biogen Inc. (Nasdaq: BIIB) announced today that Michael McDonnell, Executive Vice President and Chief Financial Officer, will retire from his role on February 28, 2025. Upon his retirement, Robin Kramer, currently Biogen’s Chief Accounting Officer, will step into the Chief…
Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura) has announced the withdrawal of its marketing authorization application from the European Medicines Agency (EMA) for avacincaptad pegol intravitreal solution (ACP). This investigational synthetic aptamer is designed to inhibit the…
enGene Holdings Inc. (Nasdaq: ENGN), a clinical-stage genetic medicines company, has announced an agreement to sell 6,758,311 of its common shares at a price of $8.90 per share. This financing round is expected to close on October 29, 2024, pending…
Seaport Therapeutics (“Seaport” or the “Company”), a clinical-stage biopharmaceutical company that is advancing novel neuropsychiatric medicines with a proven strategy and team, today announced the closing of an oversubscribed $225 million Series B financing round. The syndicate wasled by General…
Catalent Affirms Commitment to Customers and Patients Amidst Novo Holdings Acquisition Alessandro Maselli to Remain President and CEO of Catalent Post-Acquisition Catalent, Inc. (NYSE: CTLT), a leader in the development and supply of innovative treatments for patients worldwide, has released…
bioAffinity Technologies Announces $2.66 Million Registered Direct Offering and Concurrent Private Placement bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company dedicated to developing noninvasive tests for early-stage cancer detection, has entered into a securities purchase agreement with institutional investors.…
Biological Lattice Industries Corp. (BLI), an innovator in biofabrication and life sciences, has closed a $1.8 million pre-seed funding round led by Greek venture capital firm Uni.Fund. Alongside this investment, BLI is launching its first integrated biofabrication solution: BioLoom™, a…
Trinity Life Sciences has introduced a new Omnichannel Reporting Suite, offering key promotional activity insights for stakeholders in the life sciences industry. The suite aims to address a significant gap, as 32% of life science marketing and analytics teams report…
Audax Private Equity has acquired the clinical services division of Avantor, Inc. and rebranded it as Resonant Clinical Solutions (“Resonant”). Resonant comprises three established brands: EPL Archives, MESM, and Therapak, which have roots dating back to the 1970s. These brands…
The “High Potency APIs (HPAPIs) – Global Strategic Business Report” has been added to ResearchAndMarkets.com’s offerings. The global HPAPIs market was valued at $26.3 billion in 2023 and is projected to reach $46.9 billion by 2030, growing at a CAGR…